BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19728975)

  • 1. Molecular targeted enhanced ultrasound imaging of flk1 reveals diagnosis and prognosis potential in a genetically engineered mouse prostate cancer model.
    Xuan JW; Bygrave M; Valiyeva F; Moussa M; Izawa JI; Bauman GS; Klibanov A; Wang F; Greenberg NM; Fenster A
    Mol Imaging; 2009; 8(4):209-20. PubMed ID: 19728975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound.
    Xuan JW; Bygrave M; Jiang H; Valiyeva F; Dunmore-Buyze J; Holdsworth DW; Izawa JI; Bauman G; Moussa M; Winter SF; Greenberg NM; Chin JL; Drangova M; Fenster A; Lacefield JC
    Cancer Res; 2007 Mar; 67(6):2830-9. PubMed ID: 17363606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new three-dimensional ultrasound microimaging technology for preclinical studies using a transgenic prostate cancer mouse model.
    Wirtzfeld LA; Wu G; Bygrave M; Yamasaki Y; Sakai H; Moussa M; Izawa JI; Downey DB; Greenberg NM; Fenster A; Xuan JW; Lacefield JC
    Cancer Res; 2005 Jul; 65(14):6337-45. PubMed ID: 16024636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
    Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
    Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging.
    Deshpande N; Ren Y; Foygel K; Rosenberg J; Willmann JK
    Radiology; 2011 Mar; 258(3):804-11. PubMed ID: 21339349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice.
    Shen ZY; Shen E; Zhang JZ; Bai WK; Wang Y; Yang SL; Nan SL; Lin YD; Li Y; Hu B
    Oncol Rep; 2013 Aug; 30(2):842-50. PubMed ID: 23707983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound.
    Singh S; Pan C; Wood R; Yeh CR; Yeh S; Sha K; Krolewski JJ; Nastiuk KL
    BMC Urol; 2015 Sep; 15():97. PubMed ID: 26391476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US.
    McCarville MB; Streck CJ; Dickson PV; Li CS; Nathwani AC; Davidoff AM
    Radiology; 2006 Jul; 240(1):73-81. PubMed ID: 16793972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection.
    Pysz MA; Machtaler SB; Seeley ES; Lee JJ; Brentnall TA; Rosenberg J; Tranquart F; Willmann JK
    Radiology; 2015 Mar; 274(3):790-9. PubMed ID: 25322341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
    Willmann JK; Lutz AM; Paulmurugan R; Patel MR; Chu P; Rosenberg J; Gambhir SS
    Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
    Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
    Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence and Bioluminescence Imaging of Angiogenesis in Flk1-Nano-lantern Transgenic Mice.
    Matsushita J; Inagaki S; Nishie T; Sakasai T; Tanaka J; Watanabe C; Mizutani KI; Miwa Y; Matsumoto K; Takara K; Naito H; Kidoya H; Takakura N; Nagai T; Takahashi S; Ema M
    Sci Rep; 2017 Apr; 7():46597. PubMed ID: 28425492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis.
    Rychak JJ; Graba J; Cheung AM; Mystry BS; Lindner JR; Kerbel RS; Foster FS
    Mol Imaging; 2007; 6(5):289-96. PubMed ID: 18092513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?
    Wang S; Herbst EB; Mauldin FW; Diakova GB; Klibanov AL; Hossack JA
    Invest Radiol; 2016 Dec; 51(12):758-766. PubMed ID: 27654582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.
    Reynolds AR; Reynolds LE; Nagel TE; Lively JC; Robinson SD; Hicklin DJ; Bodary SC; Hodivala-Dilke KM
    Cancer Res; 2004 Dec; 64(23):8643-50. PubMed ID: 15574772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor receptor 2-specific microbubbles for molecular ultrasound detection of prostate cancer in a rat model.
    Fischer T; Thomas A; Tardy I; Schneider M; Hünigen H; Custodis P; Beyersdorff D; Plendl J; Schnorr J; Diekmann F; Gemeinhardt O
    Invest Radiol; 2010 Oct; 45(10):675-84. PubMed ID: 20733504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma.
    Wei S; Fu N; Sun Y; Yang Z; Lei L; Huang P; Yang B
    Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis and prostate cancer: identification of a molecular progression switch.
    Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM
    Cancer Res; 2001 Mar; 61(6):2736-43. PubMed ID: 11289156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.
    Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK
    Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.